Improved pulmonary and growth outcomes in cystic fibrosis by newborn screening

Pediatric Pulmonology

Volumn 43, Issue 7, 2008, Pages 648-655

  Collins, Melanie Sue ^a,b   Abbott, Mary Alice ^c   Wakefield, Dorothy B ^b   Lapin, Craig D ^a,b   Drapeau, Ginny ^a,b   Hopfer, Sidney M ^b   Greenstein, Robert M ^b   Cloutier, Michelle M ^a,b  

^a Farmington   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^c BAYSTATE MEDICAL CENTER   (United States)

Author keywords

Cystic fibrosis; Growth; Newborn screening; Pulmonary function

Indexed keywords

CHLORIDE; DNA; IMMUNOREACTIVE TRYPSINOGEN; TRYPSINOGEN;

ARTICLE; BACTERIAL COLONIZATION; BLOOD; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHILD GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; EARLY DIAGNOSIS; FEMALE; FORCED EXPIRATORY VOLUME; GENE MUTATION; HUMAN; INFECTION RISK; LABORATORY TEST; LUNG FUNCTION; MALE; NEWBORN; NEWBORN SCREENING; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; SCREENING TEST; SPIROMETRY; SWEAT;

ADOLESCENT; BODY HEIGHT; BODY WEIGHT; CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INFANT; INFANT, NEWBORN; LUNG; MALE; MASS SCREENING; TIME FACTORS; VITAL CAPACITY;

EID: 46849116240     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.20842     Document Type: Article

References (37)

1. Cystic Fibrosis Foundation Patient Registry Annual Data Report 2006. Bethesda, Maryland: Cystic Fibrosis Foundation; 2007 October 1, 2007. 12 p.
2. Farrell PM, Kosorok MR, Rock MJ, Laxova A, Zeng L, Lai HC, Hoffman G, Laessig RH, Splaingard ML. Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group. Pediatrics 2001;107:1-13.
3. Farrell PM. Improving the health of patients with cystic fibrosis through newborn screening. Wisconsin Cystic Fibrosis Neonatal Screening Study Group. Adv Pediatr 2000;47:79-115.
4. Waters DL, Wilcken B, Irwing L, Van Asperen P, Mellis C, Simpson JM, Brown J, Gaskin KJ. Clinical outcomes of newborn screening for cystic fibrosis. Arch Dis Child Fetal Neonatal Ed 1999;80:F1-F7.
5. Balnaves ME, Bonacquisto L, Francis I, Glazner J, Forrest S. The impact of newborn screening on cystic fibrosis testing in Victoria, Australia. J Med Genet 1995;32:537-542.
6. Doull IJ, Ryley HC, Weiler P, Goodchild MC. Cystic fibrosis-related deaths in infancy and the effect of newborn screening. Pediatr Pulmonol 2001;31:363-366.
7. Merelle ME, Schouten JP, Gerritsen J, Dankert-Roelse JE. Influence of neonatal screening and centralized treatment on long-term clinical outcome and survival of CF patients. Eur Respir J 2001;18:306-315.
8. Mastella G, Zanolla L, Castellani C, Altieri S, Furnari M, Giglio L, Lombardo M, Miano A, Sciuto C, Pardo F, Magazzu G. Neonatal screening for cystic fibrosis: long-term clinical balance. Pancreatology 2001;1:531-537.
9. Sims EJ, Clark A, McCormick J, Mehta G, Connett G, Mehta A. Cystic fibrosis diagnosed after 2 months of age leads to worse outcomes and requires more therapy. Pediatrics 2007;119:19-28.
10. Dankert-Roelse JE, te Meerman GJ. Long term prognosis of patients with cystic fibrosis in relation to early detection by neonatal screening and treatment in a cystic fibrosis centre. Thorax 1995;50:712-718.
11. Konstan MW, Butler SM, Wohl ME, Stoddard M, Matousek R, Wagener JS, Johnson CA, Morgan WJ. Growth and nutritional indexes in early life predict pulmonary function in cystic fibrosis. J Pediatr 2003;142:624-630.
12. Pedreira CC, Robert RG, Dalton V, Oliver MR, Carlin JB, Robinson P, Cameron FJ. Association of body composition and lung function in children with cystic fibrosis. Pediatr Pulmonol 2005;39:276-280.
13. Siret D, Bretaudeau G, Branger B, Dabadie A, Dagorne M, David V, de Braekeleer M, Moisan-Petit V, Picherot G, Rault G, Storni V, Roussey M. Comparing the clinical evolution of cystic fibrosis screened neonatally to that of cystic fibrosis diagnosed from clinical symptoms: a 10-year retrospective study in a French region (Brittany). Pediatr Pulmonol 2003;35:342-349.
14. Wang SS, FitzSimmons SC, O'Leary LA, Rock MJ, Gwinn ML, Khoury MJ. Early diagnosis of cystic fibrosis in the newborn period and risk of Pseudomonas aeruginosa acquisition in the first 10 years of life: a registry-based longitudinal study. Pediatrics 2001;107:274-279.
15. McCaffery K, Olver RE, Franklin M, Mukhopadhyay S. Systematic review of antistaphylococcal antibiotic therapy in cystic fibrosis. Thorax 1999;54:380-383.
16. Nixon GM, Armstrong DS, Carzino R, Carlin JB, Olinsky A, Robertson CF, Grimwood K. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. J Pediatr 2001;138:699-704.
17. Farrell PM, Shen G, Splaingard M, Colby CE, Laxova A, Kosorok MR. Rock MJ, Mischler EH. Acquisition of Pseudomonas aeruginosa in children with cystic fibrosis. Pediatrics 1997; 100:E2.
18. Maselli JH, Sontag MK, Norris JM, MacKenzie T, Wagener JS, Accurso FJ. Risk factors for initial acquisition of Pseudomonas aeruginosa in children with cystic fibrosis identified by newborn screening. Pediatr Pulmonol 2003;35:257-262.
19. Levy D, Orlando R, Wayne V. The Changing Demographics of Connecticut - 1990 to 2000. Part 2: The Five Connecticuts. Storrs, CT: University of Connecticut, Center for Population Research; 2004, CPR Series, no. OP 2004-01.
20. Kirby LT, Applegarth DA, Davidson AG, Wong LT, Hardwick DF. Use of a dried blood spot in immunoreactive-trypsin assay for detection of cystic fibrosis in infants. Clin Chem 1981;27:678-680.
21. Gibson LE, Cooke RE. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics 1959;23:545-549.
22. Murphy TD, Anbar RD, Lester LA, Nasr SZ, Nickerson B, VanDevanter DR, Colin AA. Treatment with tobramycin solution for inhalation reduces hospitalizations in young CF subjects with mild lung disease. Pediatr Pulmonol 2004;38:314-320.
23. Moss RB. Long-term benefits of inhaled tobramycin in adolescent patients with cystic fibrosis. Chest 2002;121:55-63.
24. Wang X, Dockery DW, Wypij D, Fay ME, Ferris BG, Jr. Pulmonary function between 6 and 18 years of age. Pediatr Pulmonol 1993;15:75-88.
25. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999;159:179-187.
26. Watson MS, Mann MY, Lloyd-Puryear MA, Rinaldo P. In: Howell RR, Editor, Newborn screening: toward a uniform screening panel and system. Genet Med 2006;8:1S-252S.
27. Rosenfeld M. Overview of published evidence on outcomes with early diagnosis from large US observational studies. J Pediatr 2005;147:S11-S14.
28. Dankert-Roelse JE, Merelle ME. Review of outcomes of neonatal screening for cystic fibrosis versus non-screening in Europe. J Pediatr 2005;147:S15-S20.
29. Lai HJ, Cheng Y, Farrell PM. The survival advantage of patients with cystic fibrosis diagnosed through neonatal screening: evidence from the United States Cystic Fibrosis Foundation registry data. J Pediatr 2005;147:S57-S63.
30. Wilfond BS, Gollust SE. Policy issues for expanding newborn screening programs: the cystic fibrosis newborn screening experience in the United States. J Pediatr 2005;146:668-674.
31. Grosse SD, Boyle CA, Botkin JR, Comeau AM, Kharrazi M, Rosenfeld M, Wilfond BS. Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs. MMWR Recomm Rep 2004;53:1-36.
32. Li Z, Kosorok MR, Farrell PM, Laxova A, West SE, Green CG, Collins J, Rock MJ, Splaingard ML. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. JAMA 2005;293:581-588.
33. Borowitz D, Baker RD, Stallings V. Consensus report on nutrition for pediatric patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 2002;35:246-259.
34. Farrell PM, Li Z, Kosorok MR, Laxova A, Green CG, Collins J, Lai HC, Rock MJ, Splaingard ML. Bronchopulmonary disease in children with cystic fibrosis after early or delayed diagnosis. Am J Respir Crit Care Med 2003;168:1100-1108.
35. Kosorok MR, Jalaluddin M, Farrell PM, Shen G, Colby CE, Laxova A, Rock MJ, Splaingard M. Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis. Pediatr Pulmonol 1998;26:81-88.
36. Farrell PM, Lai HJ, Li Z, Kosorok MR, Laxova A, Green CG, Collins J, Hoffman G, Laessig R, Rock MJ, Splaingard ML. Evidence on improved outcomes with early diagnosis of cystic fibrosis through neonatal screening: enough is enough. J Pediatr 2005;147:S30-S36.
37. Brasfield D, Hicks G, Soong S, Tiller RE. The chest roentgenogram in cystic fibrosis: a new scoring system. Pediatrics 1979; 63: 24-29.